Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
The Vice President, Business Development Transactions (Temporary) will serve as the Company's senior transaction lead for strategic partnering activities, with primary responsibility for structuring, negotiating, and executing complex business development transactions involving the Company's oncology portfolio. Reporting to the Chief Business Officer, this individual will provide expert transactional leadership across the full deal lifecycle, including confidentiality agreements, term sheets, diligence processes, definitive agreements, and post-signing governance support.
The successful candidate will partner closely with Research, Development, Commercial, Finance, Legal, Intellectual Property, Alliance Management, and Executive Leadership teams to maximize the value of the Company's clinical-stage and preclinical oncology assets through regional and global licensing, co-development, co-commercialization, collaboration, option, and platform transactions.
This role requires exceptional deal judgment, strong negotiation skills, deep understanding of biopharmaceutical transaction structures, and the ability to drive negotiations with senior executives and external counsel representing global biotechnology and pharmaceutical companies.
WHAT YOU'LL DOTransaction Leadership
- Lead, or support the CBO in leading, the negotiation and execution of strategic partnering transactions involving oncology therapeutics, technology platforms, and related intellectual property.
- Serve as one of the Company's principal negotiators for non-binding term sheets, letters of intent, option agreements, collaboration agreements, license agreements, co-development agreements, and other strategic transactions.
- Develop transaction structures and economic frameworks that maximize asset value while aligning with corporate objectives.
- Identify key business, legal, regulatory, intellectual property, financial, and operational risks and develop strategies to mitigate such risks during negotiations.
- Drive transactions from initial engagement through signing and closing, coordinating all internal stakeholders.
Deal Strategy and Structuring
- Advise senior management regarding optimal transaction structures, including:
- Global and regional licensing arrangements
- Co-development and co-commercialization partnerships
- Platform and technology licensing transactions
- Research collaborations
- Option-to-license structures
- Asset acquisitions and divestitures
- Develop and negotiate financial terms, including:
- Upfront payments, development and regulatory milestones, commercial milestones, royalties
- Profit-sharing arrangements
- Cost-sharing mechanisms
- Equity investments and related strategic considerations
Negotiation and Contracting
- Lead negotiations with counterpart business development teams, senior executives, and external counsel.
- Work closely with internal and external legal counsel to negotiate definitive agreements.
- Ensure alignment between business objectives and contractual provisions.
- Maintain consistency in transaction precedents, templates, and negotiation playbooks.
Portfolio and Business Development Support
- Support evaluation of partnering opportunities for oncology programs and technology platforms.
- Contribute to business case development and valuation analyses.
- Provide transactional expertise during partner outreach, management presentations, and negotiations.
Required
- Advanced degree in life sciences, business, law, or a related discipline (PhD, MD, MBA, JD, or equivalent preferred).
- 12+ years of biotechnology, pharmaceutical, business development, legal, investment banking, consulting, or related experience.
- Significant experience negotiating and executing biopharmaceutical licensing and collaboration transactions.
- Demonstrated expertise negotiating complex term sheets and definitive agreements.
- Deep understanding of drug development, intellectual property, regulatory pathways, and biopharmaceutical commercialization.
- Strong financial and valuation acumen.
- Excellent communication, presentation, and stakeholder management skills.
- Proven ability to influence senior executives and lead cross-functional teams.
Preferred
- Experience supporting transactions involving oncology therapeutics and immuno-oncology programs.
- Experience with both preclinical and clinical-stage assets.
- Prior experience negotiating transactions with large pharmaceutical companies.
- Familiarity with global partnering structures, including ex-U.S. regional licensing arrangements.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
Skills Required
- Advanced degree in life sciences, business, law, or related discipline (PhD, MD, MBA, JD, or equivalent)
- 12+ years of biotechnology, pharmaceutical, business development, legal, investment banking, consulting, or related experience
- Significant experience negotiating and executing biopharmaceutical licensing and collaboration transactions
- Demonstrated expertise negotiating complex term sheets and definitive agreements
- Deep understanding of drug development, intellectual property, regulatory pathways, and biopharmaceutical commercialization
- Strong financial and valuation acumen
- Excellent communication, presentation, and stakeholder management skills
- Proven ability to influence senior executives and lead cross-functional teams
- Currently authorized to work for any employer in the U.S.; employer cannot sponsor or transfer employment visas
- Experience supporting transactions involving oncology therapeutics and immuno-oncology programs
- Experience with both preclinical and clinical-stage assets
- Prior experience negotiating transactions with large pharmaceutical companies
- Familiarity with global partnering structures, including ex-U.S. regional licensing arrangements
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™. Join us as we pursue our mission to transform lives. It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
.jpg)
.png){kind=logo}
